Chance Pharmaceuticals

Chance Pharmaceuticals is a high-tech biopharmaceutical company at the clinical stage. We focus on the research and development and industrialization of inhaled products. The company owns patented technologies including dry powder formulation for inhalation and inhaler design. Our core business concentrates on the discovery, development, and industrialization of new drugs targeting diseases that significantly impact human daily life quality, including respiratory system diseases. Founded in 2015 by a group of passionate industry experts with extensive experience, the company’s vision is to fully utilize the advantages and characteristics of inhaled drug delivery technology to provide patients with treatment options that can improve their quality of life. The company holds patented dry powder preparation technology and efficient, user-friendly inhaler technology. Chance Pharmaceuticals primarily focuses on independently developed products, aiming to establish a comprehensive R&D, production, and sales industrial system in the biomedicine and medical device fields through innovative high-tech products, socially responsible practices, and a viable commercial operation model.